Literature DB >> 3343595

Effects of fencamfamine on single unit activity of mesencephalic dopaminergic neurons in rats.

R T Matthews1.   

Abstract

Systemic fencamfamine (0.5-16 mg/kg, i.v.) significantly but incompletely inhibited spontaneous activity of nigrostriatal and mesolimbic/mesocortical dopamine (DA) neurons. Inhibition was reversed by haloperidol (0.1 mg/kg, i.v.) and prevented by pretreatment with alpha-methyltyrosine (50 mg/kg, i.v.) plus reserpine (5 mg/kg, i.p.). Pretreatment with alpha-methyltyrosine alone attenuated inhibition at high but not low doses of fencamfamine. Microiontophoresed fencamfamine had little direct effect on DA neurons and did not consistently modulate the effects of co-microiontophoresed DA. In contrast, systemic fencamfamine blocked the inhibitory effects of low doses of apomorphine (10-40 micrograms/kg, i.v.). Fencamfamine appears to be an indirect DA agonist which interacts with both vesicular and newly synthesized DA storage pools. Fencamfamine may also cause a rapid desensitization to the effects of DA autoreceptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343595     DOI: 10.1007/bf01259409

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  22 in total

1.  [Pharmacological properties of 2-ethylamino-3-phenylnorcamphane].

Authors:  R HOTOVY; H J ENENKEL; J GILLISSEN; A HOFFMANN; U JAHN; H G KRAFT; H MUELLER-CALGAN; S SOMMER; R STRULLER
Journal:  Arzneimittelforschung       Date:  1961-01

2.  Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.

Authors:  J R Walters; B S Bunney; R H Roth
Journal:  Adv Neurol       Date:  1975

3.  Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.

Authors:  A J Azzaro; G R Wenger; C R Craig; R E Stitzel
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

4.  Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

Authors:  B S Bunney; G K Aghajanian; R H Roth
Journal:  Nat New Biol       Date:  1973-09-26

5.  Discriminative stimulus properties and schedule effects of fencamfamine in rats.

Authors:  M E Risner; P A Jackson-Smith; E J Cone
Journal:  Pharmacol Biochem Behav       Date:  1985-09       Impact factor: 3.533

6.  Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons.

Authors:  L A Chiodo; M J Bannon; A A Grace; R H Roth; B S Bunney
Journal:  Neuroscience       Date:  1984-05       Impact factor: 3.590

7.  A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists.

Authors:  F J White; R Y Wang
Journal:  Life Sci       Date:  1984-03-19       Impact factor: 5.037

8.  Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study.

Authors:  C A Seyfried
Journal:  Biochem Pharmacol       Date:  1983-08-01       Impact factor: 5.858

9.  On the mechanism of central stimulation action of fencamfamine.

Authors:  R DeLucia; M M Bernardi; C Scavone; M L Aizenstein
Journal:  Gen Pharmacol       Date:  1984

10.  Detection and metabolism of fencamfamine and the influence of acetazolamide on its urinary excretion.

Authors:  F T Delbeke; M Debackere
Journal:  Biopharm Drug Dispos       Date:  1981 Jan-Mar       Impact factor: 1.627

View more
  1 in total

Review 1.  New drugs on the Internet: the case of Camfetamine.

Authors:  Eduardo Cinosi; Ornella Corazza; Rita Santacroce; Matteo Lupi; Tiziano Acciavatti; Giovanni Martinotti; Massimo di Giannantonio
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.